DiaMedica Therapeutics Archives

DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement

July 9, 2024 Craig Etkin

July 01, 2024 05:00 AM Pacific Daylight Time MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced…

Minneapolis Minnesota based DiaMedica Therapeutics is raising $29,999,995.00 in New Equity Investment.

October 27, 2021 Craig Etkin

Minneapolis, MN – According to filings with the U.S. Securities and Exchange Commission, DiaMedica Therapeutics is raising $29,999,995.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Rick Pauls played a…

intelligence360

The Intelligent News Source

Tag: DiaMedica Therapeutics

DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement

July 9, 2024 Craig Etkin

Minneapolis Minnesota based DiaMedica Therapeutics is raising $29,999,995.00 in New Equity Investment.

October 27, 2021 Craig Etkin